| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 105 SH. CAVIUM | 2008-12 | DONATION | 2018-03 | 9,392 | 1,207 | 8,185 | ||||
| 100 SH. KINDER MORGAN | 2013-09 | PURCHASE | 2018-03 | 1,633 | 3,846 | -2,213 | ||||
| 15 SH, ILLUMINA INC. | 2009-11 | PURCHASE | 2018-12 | 4,897 | 408 | 4,489 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ABBVIE | 2,021 | 7,652 |
| ADOBE | 4,492 | 6,787 |
| ALEXION PHARMACEUTICAL | 2,320 | 3,894 |
| ALPHABET A | 1,678 | 10,450 |
| ALPHABET C | 1,678 | 2,071 |
| AMAZON | 3,149 | 22,530 |
| APPLE | 1,742 | 16,563 |
| BAIDU INC. | 4,368 | 4,758 |
| BANDWIDTH | 2,437 | 3,056 |
| BIOGEN | 5,211 | 4,514 |
| BOOKING HOLDINGS | 2,091 | 5,167 |
| CAVIUM INC. | ||
| CELGENE | 1,416 | 5,448 |
| COGNIZANT TECHNOLOGY | 554 | 3,809 |
| EXELIXIS | 3,460 | 2,754 |
| 5,353 | 9,176 | |
| GILEAD SCIENCES | 2,269 | 6,255 |
| ILLUMINA | 1,227 | 13,497 |
| INTUITIVE SURGICAL | 1,878 | 21,551 |
| KINDER MORGAN | ||
| LULULEMON ATHLETICA | 2,221 | 8,513 |
| MERCADOLIBRE | 2,290 | 6,443 |
| NVIDIA | 5,023 | 2,670 |
| PRICELINE | ||
| PROTOLABS | 4,821 | 7,331 |
| STARBUCKS | 1,468 | 5,796 |
| ULTA SALON COSMETICS | 4,057 | 9,794 |
| VERTEX PHARMACEUTICALS | 3,298 | 5,800 |
| VMWARE | 1,697 | 8,228 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| INVESTMENT MANAGEMENT FEES | 2,278 | 2,278 |